Is there a role for 5 α‐reductase inhibitors in transgender individuals?

AbstractAltering sex steroid levels is the mainstay in the medical treatment of transgender and gender ‐diverse individuals who pursue it. By increasing or decreasing the serum concentrations of androgens and estrogens, an individual’s body can either masculinize or feminize. This commentary will explore the important clinical question regarding whether the antiandrogen class of 5α‐reductase i nhibitors should be considered as an effective and safe treatment option for transfeminine and/or transmasculine individuals.
Source: Andrology - Category: Urology & Nephrology Authors: Tags: OPINION ARTICLE Source Type: research